Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Pediatr. Jun 9, 2026; 15(2): 117381
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.117381
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.117381
Letter to the Editor: 100-day window: Reframing early follow-up and parental guidance in recurrent wheezing
Mudasir Maqbool, Zulfkar Qadrie, Department of Pharmacology, Government Medical College, Baramula 193101, Jammu and Kashmīr, India
Co-first authors: Mudasir Maqbool and Zulfkar Qadrie.
Author contributions: Maqbool M was the conceptual developer of the editorial and headed the critical examination of the study used and prepared the original manuscript; Qadrie Z helped in the process of interpretation of clinical implications, modulation of conceptual framework, and critical review of the manuscript to achieve significant intellectual material; both authors revised, edited and signed the final copy of the editorial and are willing to be responsible towards all the works, preparation as the co-first authors.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Mudasir Maqbool, PhD, Researcher, Department of Pharmacology, Government Medical College, Kanthbagh Baramulla, Baramula 193101, Jammu and Kashmīr, India. bhatmudasir92@gmail.com
Received: December 23, 2025
Revised: January 27, 2026
Accepted: February 13, 2026
Published online: June 9, 2026
Processing time: 158 Days and 23.3 Hours
Revised: January 27, 2026
Accepted: February 13, 2026
Published online: June 9, 2026
Processing time: 158 Days and 23.3 Hours
Core Tip
Core Tip: This study examined children hospitalized with acute lower respiratory tract infections and wheezing, identifying several independent risk factors for recurrent wheezing, including age 12-24 months, prematurity, allergic rhinitis, urban residence, eosinophilia, and prior lower respiratory tract infection. Notably, the median time to recurrence was 100 days, providing practical insight for optimizing follow-up timing and early intervention strategies.